What Happened?
San Diego, CA-based Histogen has appointed Gail Naughton as Chief Executive Officer and Chairman
About the Company
A regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor. Two product families - a proprietary liquid complex of embryonic-like proteins and growth factors` and a human Extracellular Matrix (ECM) material` ExCeltrix..
About the Person
Dr. Gail Naughton founded Histogen` in 2007` and currently serves as CEO and Chairman of the Board for the Company. She has spent more than 25 years extensively researching the tissue engineering process` holds more than 95 U.S. and foreign patents` and has been extensively published in the field.
Info Source
Company Announcement
Short Profile